QR Code

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults

Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. In addition, some patients encounter delays in accessing treatment prog...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo Carvalho de Melo Rocha, Pascal Maisonobe, Thais Cuperman-Pohl, Patricia Khan
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2022-11-01
Rangatū:Toxins
Ngā marau:
abobotulinumtoxinA
patients
post-stroke
shoulder pain
spasticity
therapeutic goal
Urunga tuihono:https://www.mdpi.com/2072-6651/14/11/809
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite